Table 1.
Drug | Conventional Use | Conventional Route | Wound Resolution Indications |
---|---|---|---|
Deferoxamine (DFOA) | Treating iron/aluminum toxicity | SQ, IM, IV | Decreases oxidative stress and necrosis [16] Enhances neovascularization [17] Reduces interstitial renal fibrosis [18] |
Metyrapone (MTP) | Inhibition of adrenal steroidgenesis | PO | Enhances epithelialization [19,20] |
Rifampicin (RIF) | Antibiotic activity | PO, IV | Ulcer resolution [21] Immunomodulatory [22,23] |
Pyrvinium pamoate (PYR) | Anthelmintic activity | PO | Wnt inhibition [24] Inhibits fibroblast survival [25] |